
GC19161
GDC-0326
Also known as (2S)-2-[[2-(2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]oxy]propanamide
GDC-0326 is a potent and selective PI3Kα inhibitor with a Ki of 0·2 nM
ChemicalCAS1282514-88-8MW382.42FormulaC19H22N6O3
- CAS number
- 1282514-88-8
- Molecular weight
- 382.42
- Formula
- C19H22N6O3
- Solubility
- DMSO : ≥ 83·3 mg/mL (217·82 mM)
- InChIKey
- SIKYDKLGPWRPMZ-LBPRGKRZSA-N
- Catalogue number
- GC19161
- Brand
- GLPBIO
Computed properties PubChem CID 58204997 · XLogP 1.2 · TPSA 110 Ų · H-bond donors 1
- XLogP
- 1.2
- TPSA
- 110 Ų
- H-bond donors
- 1
- H-bond acceptors
- 6
- Rotatable bonds
- 5
- Heavy atoms
- 28
SMILES C[C@@H](C(=O)N)OC1=CC2=C(C=C1)C3=NC(=CN3CCO2)C4=NC=NN4C(C)C
Computed descriptors from PubChem (CID 58204997), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il